Skip to content

Endovascular therapy combined with operation and simple operation in the treatment of chronic subdural hematoma: a randomized controlled trial.

Clinical comparative study of burr-hole drainage and middle meningeal artery embolization combined with burr hole drainage for the management of chronic subdural hematoma

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000039359
Enrollment
Unknown
Registered
2020-10-24
Start date
2020-11-01
Completion date
Unknown
Last updated
2021-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic subdural hematoma

Interventions

controlled group:experiment group
experiment group:middle meningeal artery embolization combined with burr-hole drainage

Sponsors

Beijing Tiantan Hospital Affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients aged >= 18 and <= 70 years; 2. Patients with CSDH confirmed by CT examination (i.e. hematoma with equal or low density, or hematoma with mixed density and acute component < 50%); 3. Patients with CSDH related symptoms need surgical treatment, including headache, cognitive impairment, ataxia, epilepsy, focal neurological deficit, or decreased consciousness; 4. The patients agreed to accept the protocol and signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with previous CSDH operation history; 2. Patients with CSDH thickness less than or equal to 10 mm; 3. Patients with mixed hematoma density by CT examination, in which the acute component was more than or equal to 50%; 4. Patients with CSDH secondary to vascular disease, arachnoid cyst, intracranial tumor or after craniotomy, etc.; 5. CT examination showed that the hematoma was separated or stratified, which was not suitable for drilling and drainage; 6. Patients with severe diseases whose life expectancy is less than 1 year; 7. Patients with surgical contraindications, including poor general conditions, intolerance of surgery, severe coagulation disorders, etc.; 8. Patients taking glucocorticoid for a long time; 9. Subjects of pregnancy and lactation.

Design outcomes

Primary

MeasureTime frame
recurrence rate;

Secondary

MeasureTime frame
resolution rate;

Countries

China

Contacts

Public ContactQiu Hancheng

Beijing Tiantan Hospital Affiliated to Capital Medical University

qiuhancheng@126.com+86 15210350559

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 10, 2026